OPKO Health, Inc. (OPK)
$1.38+0.73%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.0B
- Beta
- 1.50
- P/E (TTM)
- -15.32
- Short % float
- 10.81%
- Days to cover
- 14.9
- SI change
- -1.2%
- 1W
- -11.54%
- 1M
- -7.38%
- vs SPY 1W
- -12.70%
- vs SPY 1M
- -10.37%
Industry peers
FMP comparable companies · ranked by market cap
- NTRABUYNatera, Inc.$56.0BBULLQ 30$390.79+2.54%
- GHSELLGuardant Health, Inc.$22.2BBULLQ 23$165.56+1.15%
- BLLNSELLBillionToOne, Inc.$4.4BCRISISQ -7$95.41+2.81%
- PSNLSELLPersonalis, Inc.$1.7BRECOVERYQ 6$16.06-0.37%
- CSTLSELLCastle Biosciences, Inc.$1.0BRECOVERYQ 12$33.71+2.11%
- FLGTBUYFulgent Genetics, Inc.$591MRECOVERYQ 13$20.82+4.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on OPK?
- LOPJLB’s latest quantitative signal on OPKO Health, Inc. (OPK) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is OPK in?
- OPKO Health, Inc. (OPK) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does OPKO Health, Inc. (OPK) do?
- OPKO Health, Inc. operates as a healthcare enterprise with a dual focus on diagnostics and pharmaceuticals. Its operations span the United States, Ireland, Chile, Spain, Israel, Mexico, and other international markets. The company's Diagnostics division encompasses BioReference Laboratories, which delivers a comprehensive suite of laboratory testing services. These services are crucial for dise…